US Food and Drug Administration approves new treatment for chronic
Therapeutics Daily (subscription) (press release), PA - 11 hours ago
2006 NOV 13 - (NewsRx.com) — The US Food and Drug Administration (FDA) approved Tyzeka (telbivudine) for the treatment of adults with chronic hepatitis B (HBV
Taxotere receives US FDA approval for treatment for patients with Therapeutics Daily (subscription) (press release)
all 3 news articles